Showing results (631-640 of 669) with videos related to

Sort By:
Pageof 67
Hemasphere|June 5, 2025
New horizons in the pharmacological management of venous thromboembolismAndreas Verstraete, Quentin Van Thillo, Thomas Vanassche, et al.
Hemasphere|March 4, 2024
Analysis of immunoglobulin/T-cell receptor repertoires by high-throughput RNA sequencing reveals a continuous dynamic of positive clonal selection in follicular lymphomaVictor Bobée, Mathieu Viennot, Vinciane Rainville, et al.
Hemasphere|April 3, 2024
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplantPrashant R Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Hemasphere|July 5, 2024
Fibrinogen-like 1: A hepatokine linking liver physiology to hematologyJean Personnaz, Hervé Guillou, Léon Kautz
Hemasphere|September 13, 2024
The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosisNaja Nyffenegger, Anna Flace, Ahmet Varol, et al.
Hemasphere|October 9, 2024
Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCLAlfredo Rivas-Delgado, Cristina López, Guillem Clot, et al.
Hemasphere|October 9, 2024
Safe and potent anti-CD19 CAR T-cells with shRNA-IL-6 gene silencing element in patients with refractory or relapsed B-cell acute lymphoblastic leukemiaJin-Feng Ma, Jia-Wei Yan, Mei-Jing Liu, et al.
Hemasphere|October 9, 2024
Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide studyGian Matteo Rigolin, Pier Paolo Olimpieri, Valentina Summa, et al.
Hemasphere|July 31, 2024
Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life studyAxel André, Lydia Montes, Damien Roos-Weil, et al.
Hemasphere|May 22, 2025
Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemiaTim R Mocking, Arjan A van de Loosdrecht, Jacqueline Cloos, et al.
Pageof 67